Keywords: Forest Labs, Merz, Mylan, Namenda, Impax, Opana

Forest/Merz settle with Mylan and others of generic Namenda; Impax’ generic Opana cleared in USA

Article | 23 July 2010

US generic drugmaker Mylan says that it has entered into settlement and license agreements with Forest Laboratories and Merz Pharmaceuticals ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in